This article has been updated with information from Roche's earnings call.

NEW YORK (GenomeWeb) – Roche today reported a 7 percent increase in sales of its diagnostics division in 2018, driven by high demand for immunodiagnostic solutions, which are part of its Centralized and Point of Care Solutions business.

Overall, Roche reported CHF 56.85 billion ($57.21 billion) in revenues for the year, up 7 percent from CHF 53.3 billion in 2017.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.